My take on the most clinically relevant developments in diabetes care from ADA 2021.
Read these expert commentaries from Anne Peters, MD, and Martin J. Abrahamson, MD, FACP, summarizing key data from ADA 2021 and how it may influence your practice.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.